Shasun Pharmaceuticals, a global pharmaceutical organization offering world class capabilities and facilities has successfully completed MHRA inspection at its manufacturing facility in Dudley, UK during the third week of October 2013. The main focus of the inspection was to conduct a cGMP audit for its UK CRAMS Shasun Pharma Solutions (SPSL) facility. The inspection concluded that the facility, systems and practices comply with MHRA requirements.
Sun Pharmaceuticals Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.
